SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Julius Caesar

PatientJulius Caesar
Date of birth1972-07-12
IdentifiersMRN HR-AC001-SYN; SSN (made up) 000-01-6022
Document date2026-10-06
AuthorLucius Fairbanks-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Julius Caesar returns for his adult preventive visit three weeks after his four-week review. The cold has gone. He has had no seizure or spell since starting levetiracetam seven weeks ago and has missed no doses. He takes lisinopril 10 mg, amlodipine 5 mg (added three weeks ago), atorvastatin 80 mg, and aspirin 81 mg without side effects; his home blood pressure readings have been 122 to 132 over 76 to 82. He is sleeping about seven hours a night, has a driver for all journeys, and rides only with a companion. He completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 54
Active conditionsFocal epilepsy with a vascular cause; chronic left temporal infarct; hypertension; hyperlipidemia
MedicinesLevetiracetam 500 mg twice daily, lisinopril 10 mg, amlodipine 5 mg, atorvastatin 80 mg, aspirin 81 mg
Since the last visitCold resolved; no seizure; home blood pressure 122 to 132 over 76 to 82
Functional statusIndependent; working full days with less evening work

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood
PsychosocialDemanding public work, supported by his staff; married; no money worries
BehavioralNever smoker; a glass of wine once or twice a week (AUDIT-C 1); no other drug use; walks daily and rides at weekends with a companion
NutritionMediterranean-style diet since the last visits; less salt
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages his own medicines with a weekly pill box
Home safetySmoke detectors working; showers rather than baths; no firearms
SleepAbout seven hours a night; vivid dreams less frequent
DrivingNot driving; a driver for all journeys
Hearing and visionNo hearing concern; reading glasses; no eye examination for three years
FallsNo falls apart from the collapse before his first visit

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; no fever or night sweats
EyesNegativeNo double or blurred vision
Ears, nose, mouth, and throatNegativeCold resolved; tongue healed
CardiovascularNegativeNo chest pain, palpitations, or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo indigestion, bleeding, or change in bowel habit
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalNegativeNo muscle aches on atorvastatin
IntegumentaryNegativeNo rash or easy bruising
NeurologicalNegativeNo spell, weakness, numbness, or speech change; occasional mild tension headaches
PsychiatricNegativeMood steady; PHQ-2 score 0; no irritability now

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-08-04activeS
Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily500 mg twice daily, morning and eveningOral route2026-08-18activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtimeOral route2026-08-18activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyOne tablet by mouth daily with foodOral route2026-08-18activeS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for fever or sore throat (no more than 3 g a day)One or two tablets every 6 hours as needed, at most 3 g a day, for up to a weekOral route2026-09-08 to 2026-09-14completedS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth each morningOral route2026-09-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-06Body height182cmS
2026-10-06Body weight75.2kgS
2026-10-06Body mass index (BMI) [Ratio]22.7kg/m2S
2026-10-06Systolic blood pressure128mm[Hg]S
2026-10-06Diastolic blood pressure80mm[Hg]S
2026-10-06Heart rate66/minS
2026-10-06Respiratory rate14/minS
2026-10-06Body temperature36.6CelS
2026-10-06Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-06Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-06Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 2026-10-06; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; BMI 22.7
EyesPupils equal and reactive; fundi show mild arteriolar narrowing
Ears, nose, and throatNormal
NeckNo bruit; no thyroid enlargement or nodes
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryClear
AbdomenSoft, non-tender; no aortic pulsation felt
MusculoskeletalNormal range of motion
NeurologicalNo focal deficit; normal gait
SkinNo suspicious lesions
PsychiatricCalm and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent transient episodes of collapse: six days ago a witnessed collapse with stiffening and jerking of both arms for about a minute, a bitten tongue, and about twenty minutes of confusion, after a rising strange feeling and dizziness; two briefer spells of staring and unresponsiveness in the past eighteen months; cause not yet known (seizure, convulsive syncope, or transient ischemic attack)resolvedconfirmed R56.9S — Synthetic presenting problem anchored to the documented accounts of falling attacks and fainting fits; it resolves when the cause is found.
Hypertension, stage 2: 152/94 and 148/92 mmHg today; told of high blood pressure about three years ago and never treatedactiveconfirmed I10S — Synthetic vascular risk factor; no blood pressure from his lifetime is known.
Hyperlipidemia: LDL 158 mg/dL, triglycerides 170 mg/dL, HDL 44 mg/dLactiveconfirmed E78.5S — Synthetic vascular risk factor; no lipid value from his lifetime is known.
Focal epilepsy with a structural vascular cause: focal impaired-awareness seizures with automatisms, one evolving to a bilateral tonic-clonic seizure, arising from a chronic left temporal cortical infarct, with left temporal sharp waves on EEGactiveconfirmed G40.209S — Synthetic modern diagnosis anchored to the documented falling attacks; the ILAE 2017 seizure types and a structural cause are chosen for teaching and make no claim about what he had.
Chronic left posterior temporal cortical infarct, not recognized before the seizures, with moderate small-vessel white matter disease and a non-stenotic left carotid plaque; no residual deficitactiveconfirmed I69.398S — Synthetic modern finding anchored to the retrospective cerebrovascular hypothesis; it makes no claim about his real brain.
Acute viral upper respiratory infection with low-grade fever and poor sleep, three weeks after starting levetiracetam; rapid COVID-19 and influenza tests negative; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness, chosen to teach cold-remedy choices with hypertension, aspirin, and an antiseizure medicine, and sleep loss as a seizure trigger; it echoes no documented illness.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 2026-2027Completed todayInactivated vaccine given today
Pneumococcal vaccineCompleted todayRecommended for all adults from age 50; PCV20 given today; no further pneumococcal dose needed
Recombinant zoster vaccineCompleted todayDose 1 of 2 today; dose 2 in two to six months
COVID-19 vaccine, 2026-2027DueOffered; he will have it at his pharmacy next week, away from today's three vaccines
Tetanus, diphtheria, and pertussis boosterUp to dateTdap about seven years ago; next due in about three years
Hepatitis B vaccineUp to dateHe reports a completed series as a young army officer; record requested
Hepatitis C, hepatitis B, and HIV screeningOrderedOne-time screening for adults; no earlier result on record; drawn today with his consent
Blood pressureCompleted today128/80 mmHg on two medicines; target below 130/80 mmHg
CholesterolUp to dateOn atorvastatin 80 mg since the infarct was found; lipid panel due at the ten-week review
Diabetes screeningUp to dateHbA1c 5.6 percent at intake; repeat in three years, or yearly if it reaches 5.7
Colorectal cancer screeningOrderedNever screened; recommended from 45. He chose colonoscopy, which is booked; aspirin can be continued for the procedure
Prostate cancer screeningNot indicatedShared decision-making about PSA testing begins at 55; to be discussed at next year's visit
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 1
Tobacco useCompleted todayNever smoker
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever smoker; under the starting age for aneurysm screening
Eye examinationDueNone for three years; fundi show mild hypertensive narrowing; he will book an optometrist

Immunizations given today: Influenza vaccine, 2026-2027 season; Recombinant zoster vaccine, dose 1 of 2; Pneumococcal conjugate vaccine (PCV20), single dose [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Hepatitis C, hepatitis B, and HIV results by message. Colonoscopy as booked. Second zoster dose in two to six months. Ten-week chronic-care review in three weeks. Next preventive visit in one year. Next scheduled visit 2026-10-27: ten-week review: seizure control, lipids on atorvastatin, blood pressure, and driving and safety. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent, prompted by the finding of an old infarct on his scan. He named a health care agent and completed a health care power of attorney form; the agent is recorded in the chart and is not named here. He said he would want full treatment for any new stroke or prolonged seizure, including thrombolysis or thrombectomy if offered, and wants his agent and his neurologist told at once if he is admitted. He chose not to record other treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]